标题
Rifabutin for the Treatment of Helicobacter pylori Infection: A Review
作者
关键词
-
出版物
Pathogens
Volume 10, Issue 1, Pages 15
出版商
MDPI AG
发表日期
2020-12-28
DOI
10.3390/pathogens10010015
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Rifabutin-Based Triple Therapy (RHB-105) for Helicobacter pylori Eradication
- (2020) David Y. Graham et al. ANNALS OF INTERNAL MEDICINE
- Rescue therapy with rifabutin regimen for refractory Helicobacter pylori infection with dual drug-resistant strains
- (2020) Chia-Jung Kuo et al. BMC GASTROENTEROLOGY
- Rifabutin-Based Triple Therapy Or Bismuth-Based Quadruple Regimen As Rescue Therapies For Helicobacter pylori Infection
- (2020) Ilaria M. Saracino et al. European Journal of Internal Medicine
- Efficacy and safety of a new rifabutin‐based triple therapy with vonoprazan for refractory Helicobacter pylori infection: A prospective single‐arm study
- (2020) Yoshihiro Hirata et al. HELICOBACTER
- Rifamycin use for treatment of Helicobacter pylori infection: a review of recent data
- (2020) Lyudmila Boyanova et al. Future Microbiology
- European Registry on Helicobacter pylori management (Hp-EuReg): patterns and trends in first-line empirical eradication prescription and outcomes of 5 years and 21 533 patients
- (2020) Olga P Nyssen et al. GUT
- Rifabutin triple therapy for first‐line and rescue treatment of Helicobacter pylori infection: a systematic review and meta‐analysis
- (2020) Rachel Gingold‐Belfer et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- Rifabutin-Containing Triple Therapy (RHB-105) for Eradication of Helicobacter pylori: Randomized ERADICATE Hp Trial
- (2020) Ira N. Kalfus et al. Antibiotics-Basel
- Alternative eradication regimens for Helicobacter pylori infection in Indonesian regions with high metronidazole and levofloxacin resistance
- (2019) Muhammad Miftahussurur et al. Infection and Drug Resistance
- Effective therapeutic regimens in two South Asian countries with high resistance to major Helicobacter pylori antibiotics
- (2019) Muhammad Miftahussurur et al. Antimicrobial Resistance and Infection Control
- Five alternative Helicobacter pylori antibiotics to counter high levofloxacin and metronidazole resistance in the Dominican Republic
- (2019) Muhammad Miftahussurur et al. PLoS One
- Helicobacter pylori Infection
- (2019) Sheila E. Crowe NEW ENGLAND JOURNAL OF MEDICINE
- Reconciliation of Recent Helicobacter pylori Treatment Guidelines in a Time of Increasing Resistance to Antibiotics
- (2019) Carlo A. Fallone et al. GASTROENTEROLOGY
- Rifabutin-Based Rescue Therapy for Helicobacter pylori Eradication: A Long-Term Prospective Study in a Large Cohort of Difficult-to-Treat Patients
- (2019) Davide Ribaldone et al. Journal of Clinical Medicine
- Rifabutin and Furazolidone Could Be the Candidates of the Rescue Regimen for Antibiotic-Resistant H. pylori in Korea
- (2019) Youn I Choi et al. Canadian Journal of Infectious Diseases & Medical Microbiology
- Protocol of the European Registry on the management of Helicobacter pylori infection (Hp‐EuReg)
- (2019) Adrian G. McNicholl et al. HELICOBACTER
- Primary and secondary antibiotic resistance of Helicobacter pylori in Korea from 2003 to 2018
- (2019) Ju Yup Lee et al. HELICOBACTER
- Broad spectrum resistance in Helicobacter pylori isolated from gastric biopsies of patients with dyspepsia in Cameroon and efflux-mediated multiresistance detection in MDR isolates
- (2019) Laure Brigitte Kouitcheu Mabeku et al. BMC INFECTIOUS DISEASES
- Effective antimicrobial activity of rifabutin against multidrug-resistant Helicobacter pylori
- (2018) Farideh Siavoshi et al. HELICOBACTER
- Helicobacter pylori antimicrobial resistance during a 5-year period (2013-2017) in northern Spain and its relationship with the eradication therapies
- (2018) Angel Cosme et al. HELICOBACTER
- Molecular characterization of Helicobacter pylori resistance to rifamycins
- (2017) Constantin Hays et al. HELICOBACTER
- Optimization strategies aimed to increase the efficacy of H. pylori eradication therapies
- (2017) Javier P. Gisbert et al. HELICOBACTER
- Antimicrobial susceptibility testing before first-line treatment for Helicobacter pylori infection in patients with dual or triple antibiotic resistance
- (2017) Angel Cosme et al. WORLD JOURNAL OF GASTROENTEROLOGY
- IV Conferencia Española de Consenso sobre el tratamiento de la infección por Helicobacter pylori
- (2016) Javier P. Gisbert et al. Gastroenterologia y Hepatologia
- The Toronto Consensus for the Treatment of Helicobacter pylori Infection in Adults
- (2016) Carlo A. Fallone et al. GASTROENTEROLOGY
- Management ofHelicobacter pyloriinfection—the Maastricht V/Florence Consensus Report
- (2016) P Malfertheiner et al. GUT
- Rifabutin Containing Triple Therapy and Rifabutin with Bismuth Containing Quadruple Therapy for Third-Line Treatment ofHelicobacter pyloriInfection: Two Pilot Studies
- (2016) Antonio Francesco Ciccaglione et al. HELICOBACTER
- Rifabutin Triple Therapy is Effective in Patients With Multidrug-resistant Strains of Helicobacter pylori
- (2016) Giulia Fiorini et al. JOURNAL OF CLINICAL GASTROENTEROLOGY
- Rifamycins, Alone and in Combination
- (2016) David M. Rothstein Cold Spring Harbor Perspectives in Medicine
- Rescue Therapy Using a Rifabutin-Based Regimen is Effective for Cure ofHelicobacter pyloriInfection
- (2016) Sander Veldhuyzen van Zanten et al. CANADIAN JOURNAL OF GASTROENTEROLOGY
- Different antibiotic susceptibility between antrum and corpus of the stomach, a possible reason for treatment failure ofHelicobacter pyloriinfection
- (2016) Michael Selgrad et al. WORLD JOURNAL OF GASTROENTEROLOGY
- In vitroantimicrobial susceptibility ofHelicobacter pylorito nine antibiotics currently used in Central Italy
- (2015) Mara Di Giulio et al. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY
- Rescue Therapy with a Proton Pump Inhibitor Plus Amoxicillin and Rifabutin forHelicobacter pyloriInfection: A Systematic Review and Meta-Analysis
- (2015) Xiaoqun Liu et al. Gastroenterology Research and Practice
- Rifabutin-based 10-day and 14-day triple therapy as a third-line and fourth-line regimen for Helicobacter pylori eradication: A pilot study
- (2015) Hideki Mori et al. United European Gastroenterology Journal
- Helicobacter Pylori First-Line and Rescue Treatments in the Presence of Penicillin Allergy
- (2014) Javier P. Gisbert et al. DIGESTIVE DISEASES AND SCIENCES
- Rifabutin-based High-dose Proton-pump Inhibitor and Amoxicillin Triple Regimen as the Rescue treatment forHelicobacter pylori
- (2014) Hyun Chul Lim et al. HELICOBACTER
- Second and third line treatment options forHelicobacter pylorieradication
- (2014) Mingjun Song WORLD JOURNAL OF GASTROENTEROLOGY
- Antimicrobial susceptibility of Helicobacter pylori isolates from Lower Silesia, Poland
- (2013) Monika Maria Biernat et al. Archives of Medical Science
- Antibiotic susceptibility of Helicobacter pylori in central Germany and its relationship with the number of eradication therapies
- (2013) Michael Selgrad et al. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
- Effect of Fluoroquinolone Resistance on 14-day Levofloxacin Triple and Triple Plus Bismuth Quadruple Therapy
- (2013) Jingxian Liao et al. HELICOBACTER
- Helicobacter pylori resistance rates for levofloxacin, tetracycline and rifabutin among Irish isolates at a reference centre
- (2013) A. O’Connor et al. IRISH JOURNAL OF MEDICAL SCIENCE
- Changing pattern of antibiotic resistance ofHelicobacter pyloriin children during 20 years in Jinju, South Korea
- (2013) Ji-Hyun Seo et al. PEDIATRICS INTERNATIONAL
- Fourth-line rescue therapy with rifabutin in patients with three Helicobacter pylori eradication failures
- (2012) J. P. Gisbert et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Is Helicobacter pylori antibiotic resistance surveillance needed and how can it be delivered?
- (2012) C. A. M. McNulty et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Helicobacter pylorieradication in Western Australia using novel quadruple therapy combinations
- (2012) C. Y. Tay et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Resistance rates of metronidazole and other antibacterials inHelicobacter pylorifrom previously untreated patients in Norway
- (2012) Astri L. Larsen et al. APMIS
- Culture-based Selection Therapy for Patients Who Did Not Respond to Previous Treatment for Helicobacter pylori Infection
- (2012) Giulia Fiorini et al. Clinical Gastroenterology and Hepatology
- Helicobacter pyloriresistance to antibiotics in Europe and its relationship to antibiotic consumption
- (2012) Francis Megraud et al. GUT
- The challenge of Helicobacter pylori resistance to antibiotics: the comeback of bismuth-based quadruple therapy
- (2012) Francis Mégraud Therapeutic Advances in Gastroenterology
- Review article: non-bismuth quadruple (concomitant) therapy for eradication of Helicobater pylori
- (2011) J. P. Gisbert et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Review article: the effectiveness of standard triple therapy for Helicobacter pylori has not changed over the last decade, but it is not good enough
- (2011) J. P. Gisbert et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Review article: rifabutin in the treatment of refractory Helicobacter pylori infection
- (2011) J. P. Gisbert et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Helicobacter pylori Resistance to Rifabutin in the Last 7 Years
- (2011) Toshihiro Nishizawa et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Helicobacter pylori isolates from proximal and distal stomach of patients never treated and already treated show genetic variability and discordant antibiotic resistance
- (2011) Leonardo Marzio et al. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
- High Helicobacter pylori Resistance to Metronidazole but Zero or Low Resistance to Clarithromycin, Levofloxacin, and Other Antibiotics in Malaysia
- (2011) Khean-Lee Goh et al. HELICOBACTER
- One-Week Once-Daily Triple Therapy with Esomeprazole, Moxifloxacin, and Rifabutin for Eradication of Persistent Helicobacter pylori Resistant to Both Metronidazole and Clarithromycin
- (2010) Stephan Miehlke et al. HELICOBACTER
- Bismuth improves PPI-based triple therapy for H. pylori eradication
- (2010) Peter Malfertheiner Nature Reviews Gastroenterology & Hepatology
- Past Rifampicin Dosing Determines Rifabutin Resistance of Helicobacter pylori
- (2009) Shoji Suzuki et al. DIGESTION
- Efficacy of four different moxifloxacin-based triple therapies for first-line H. pylori treatment
- (2009) F. Sacco et al. DIGESTIVE AND LIVER DISEASE
- Frequency and molecular characteristics of ciprofloxacin- and rifampicin-resistant Helicobacter pylori from gastric infections in the UK
- (2009) S. A. Chisholm et al. JOURNAL OF MEDICAL MICROBIOLOGY
- Cumulative H. pylori Eradication Rates in Clinical Practice by Adopting First and Second-Line Regimens Proposed by the Maastricht III Consensus and a Third-Line Empirical Regimen
- (2008) Theodore Rokkas et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- “Rescue” regimens after Helicobacter pylori treatment failure
- (2008) Javier P Gisbert WORLD JOURNAL OF GASTROENTEROLOGY
- Second-Line Rescue Therapy With Levofloxacin After H. pylori Treatment Failure: A Spanish Multicenter Study of 300 Patients
- (2007) Javier P Gisbert et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started